Return to the home page. top banner right
top banner bottom
Click to search.
members
Login:
Password:
Click to login
Click for Log In Help
Click to Join the Society
 
Learn more about the Society's Sudden Cardiac Arrest Awareness Campaign
 
 
 
Click for the Heart Rhythm Foundation
Click for the IBHRE (formerly NASPExAM)
Click for Professional Education
Click for Health Policy
 
 
 
 
 
Click for Clinical Guidance
Click for Research
Click for News & Information
Click for Scientific Sessions
Click for the HRS Calendar
Click for the HeartRhythm Journal
Click for the HRS Store
Click to Find a Specialist
Click for Patient Information
Click for About HRS
Click for Membership
Click for Career Center
Click for the AF 360° Resource Center
Click for the SCA 360° Resource Center
titlelines Food & Drug Administration (FDA)
As part of the Heart Rhythm Society’s Recommendations on Device Performance, the Society recommends that Congress recognize the importance of post-market surveillance, analysis, and reporting of ICDs and pacemakers in ensuring patient safety.
content_line

As noted above, the Heart Rhythm Society recommends that Congress recognize the importance of post-market surveillance, analysis, and reporting of ICDs and pacemakers in ensuring patient safety. However, the Food & Drug Administration (FDA) does not currently have the resources to make the necessary enhancements to the surveillance systems.

Funding for the FDA has not kept pace with inflation, while the agency’s responsibilities have expanded. In order to ensure that Congress makes the required commitment to ensure timely access to safe medical devices and restore public confidence in the agency, the Society has joined forces with more than 180 members to form the Alliance for a Stronger FDA, which is comprised of patient groups, nonprofit organizations, consumer advocates, public health organizations and companies from the food, pharmaceutical and medical devices sector, as well as three former Secretaries of the U.S. Department of Health and Human Services and six former FDA commissioners.

2011

Medical Device Patient Safety Act Introduced in the Senate (12/15/2011) — On Thursday, December 15, 2011, U.S. Senators Chuck Grassley (R-IA), Richard Blumenthal (D-CT) and Herb Kohl (D-WI) introduced legislation that would enhance the Food and Drug Administration oversight of medical device recalls, as well as the post-market surveillance and data collection tools. Learn more »

2009

House of Representatives Passes FY09 Appropriation (03/04/2009) — The U.S. House of Representatives passed the Fiscal Year (FY) 2009 appropriation on a vote of 245 to 178. This omnibus legislation (HR 1105) includes FY09 funding for nine appropriation bills, including Agriculture, Rural Development, FDA and Labor–Health and Human Services (HHS)–Education, not enacted last year because of disagreement between Democrats and President George W. Bush over spending levels. All health-related provisions increased over FY08. Learn more »

2008

The Alliance for a Stronger FDA recommends $2.25 billion for FY 2010 FDA Appropriation  (12/03/2008) — The Alliance for a Stronger FDA sent a letter on November 24 to President-Elect Obama's transition team recommending the amount of $2.25 billion for the FY 2010 funding to ensure that the Agency has the resources it needs to fulfill its mission. Learn more »

The Society Continues Congressional Visits to Ensure Resources for Device Safety (02/2008) — As part of the Alliance for a Stronger FDA, the Heart Rhythm Society met with the offices of Representative Jo Ann Emerson (R-MO), member of the Appropriations Committee and Senator Sam Brownback (R-KS), ranking member of the Subcommittee on Financial Services and General Government to talk about the funding of FDA. Learn more »

Click to Email Page. Click to Print Page.
Click to Contact Us.Click for the Site Map.
© Heart Rhythm Society | 1400 K St. NW, Suite 500 | Washington DC 20005 | (202) 464-3400 | Fax: (202) 464-3401 | Privacy Policy